News & Publications
(Jul 22, 2008) BRAIN expands its BioArchive by the acquisition of genetic resources for White Biotech screening from MerLion Pharmaceuticals GmbH (English)
(Jul 22, 2008) BRAIN akquiriert Genressourcen der MerLion Pharmaceuticals GmbH für Weiße Biotech Anwendungen aus erweitertem BioArchiv (German)
(Dec 6, 2007) MerLion Pharmaceuticals Wins Prestigious Pharmaceutical Industry Scrip Award
(Sep 26, 2007) MerLion Pharmaceuticals initiates Phase 1 clinical study of
Finafloxacin, a novel 'pH activated' antibiotic
(Jul 19, 2007) Singapore's biodiversity provides potential natural drug cures
(Jul 2, 2007) MerLion Pharmaceuticals initiates Phase I clinical study of Friulimicin B, a novel lipopeptide antibiotic
(Jun 13, 2007) Evotec AG acquires NMR Fragment-Based Drug Discovery Business from MerLion Pharmaceuticals' subsidiary, Combinature Biopharm AG
(Jun 6, 2007) Fierce Biotech Names MerLion Pharmaceuticals as One of the "Fierce 15" Biotech Companies of 2007
(Mar 22, 2007) MerLion Pharmaceuticals and Merck Banyu enter a new drug discovery alliance
Extension of four-year collaboration with Merck & Co Inc.
(Mar 1, 2007) Mr. David Dally joins MerLion Pharmaceuticals' Senior Management Team as CFO. MerLion announces the successful closure of its US$30M Series B round of financing.
(Feb 13, 2007) Dr. Lynn Silver joins MerLion Pharmaceuticals' Scientific Advisory Board.
|
|
|
|